CREBRF

Across TCGA pan-cancer cohorts, CREBRF mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CREBRF’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where CREBRF mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types CREBRF is over-expressed in tumor, although a few such as LSCC and LUAD show the opposite, repressed pattern.

LSCC, LUAD, and CCRCC are the cancer types where CREBRF tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CREBRF mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Male	III,IV	−0.628	<.001	8	view →
LUAD	Female	II,III,IV	−0.434	<.001	8	view →
CCRCC	Male	All	+0.223	<.001	4	view →
PDAC	Male	All	−0.544	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CREBRF–LSCC

Open the LSCC breakdown →